VEGF Levels and Ovarian Cancer Prognosis
Author Information
Author(s): Fujimoto J, Sakaguchi H, Aoki I, Khatun S, Tamaya T
Primary Institution: Gifu University School of Medicine
Hypothesis
Does the level of vascular endothelial growth factor (VEGF) in metastatic lesions of ovarian cancers affect patient prognosis?
Conclusion
Higher levels of VEGF in metastatic lesions are associated with a significantly poorer survival rate in ovarian cancer patients.
Supporting Evidence
- Increased VEGF levels were found in 8 out of 30 cases.
- Patients with increased VEGF levels had a 0% survival rate at 24 months.
- Patients with stable VEGF levels had a 68% survival rate at 24 months.
Takeaway
This study found that if a cancer has a lot of a certain protein called VEGF, the patients might not live as long.
Methodology
The study analyzed VEGF levels in primary and metastatic ovarian cancer lesions and correlated these levels with patient survival rates.
Limitations
The sample size was relatively small, which may limit the generalizability of the findings.
Statistical Information
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website